An 81-year-old woman was admitted to the emergency department with reduced general condition and diarrhea for 2 weeks. Physical examination, sonography of the abdomen and ECG showed no pathologies. Fever was not present. Peripheral O~2~-saturation was 86%. Laboratory test showed an infection constellation.

A non-enhanced (NE) chest CT revealed peripheral ground-glass opacity (GGO) with visible intralobular lines ("crazy-paving") of the left upper lobe ([Figure 1](#fig0005){ref-type="fig"} A/B).Figure 1(A) Initial CT-Scan; axial lung window: red arrow indicates peripheral ground-glass opacity/ visible intralobular lines ("crazy-paving") (B) Initial CT- Scan; coronal lung window: red arrow indicates peripheral ground-glass opacity/ visible intralobular lines ("crazy-paving"). (C) Follow up CT-Scan; axial lung window: red arrow indicates pleural-based opacification- consistent with a post-infarction pneumonia (D) Follow up CT-Scan; axial mediastinal window: red arrow indicates pulmonary embolism (PE).Figure 1

Although this is a typical infiltrate pattern of COVID-19 pneumonia, the unilateral changes were consistent with an intermediate appearance of COVID-19 pneumonia according to the recently published RSNA COVID-19 reporting consensus statement, where the intermediate appearance is defined as presence of multifocal, diffuse, perihilar, or unilateral GGO (...) and absence of typical features, in our case the missing bilaterality ([@bib0010]).

As further testing revealed elevated D-Dimer as well as a negative RT-PCR regarding Covid-19, a contrast-enhanced (CE) chest CT was indicated 2 days after initial NE-chest CT. In this CE-chest CT the aforementioned ground-glass opacity can be depicted as dome-shaped, pleural-based opacification, consistent with a post-infarction pneumonia ([Figure 1](#fig0005){ref-type="fig"} C) due to pulmonary embolism (PE) ([Figure 1](#fig0005){ref-type="fig"} D).

The patient was admitted to ICU because of progressive right heart compromise. The PE was treated with low-molecular-weight heparin.

This image shows that structured reporting of possible COVID-19 CT findings can lead the clinician to e.g. further testing and has potential to accelerate managing of patients through the workup during these difficult times, especially under the ongoing discussion of the value of D-dimer in COVID-19 patients ([@bib0005]).
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